Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.
Three buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
Cochlear Limited (ASX: COH)
According to a note out of Citi, its analysts have retained their buy rating and $198.00 price target on this hearing solutions company’s shares after it announced the launch of the Nucleus Profile Plus Series cochlear implant. Citi’s analysts appear pleased with the news and feel more confident with their growth forecasts now. The broker expects the product to be on sale in all of its key markets by FY 2020. I’m a big fan of Cochlear and would have to agree with Citi on this recommendation.
Premier Investments Limited (ASX: PMV)
Analysts at UBS have retained their buy rating and $19.80 price target on this retail conglomerate’s shares. According to the note, the broker believes the market is undervaluing its key Smiggle business. Its analysts feel this is unjustified and has created a buying opportunity for investors. Whilst I do agree with UBS on Premier Investments, I do have a few concerns over the company’s recent decision to change its Smiggle growth strategy once again.
NEXTDC Ltd (ASX: NXT)
A note out of Goldman Sachs reveals that its analysts have retained their buy rating and $7.75 price target on the shares of this data centre operator following its appearance at the investment bank’s Tenth Annual Small and Mid-Cap Conference. According to the note, the broker is confident that the company’s next round of facilities will generate healthy returns, even after factoring in a conservative pricing outlook. In addition to this, it expects NEXTDC to take advantage of the industry-wide tailwinds of cloud migration (both public and private) and growth in big data. I agree with NEXTDC that its shares could be a great buy and hold option.
And here are three more top growth shares that have recently been named as buys by a leading analyst.
You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.
So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!
Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...
While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...
Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.
You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!
James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia owns shares of and has recommended Premier Investments Limited. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.